Graham K. Cooper, CFO and Treasurer at Orexigen Therapeutics, Inc. (OREX), sold 82,500 shares at $8.36 ($678K) on 2009-12-21, disclosed to the SEC on 2009-12-23.
Open-market sale of $678k OREX by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.17 | 701 | $6K | 0.8% |
| 2 | $8.17 | 5,277 | $43K | 6.4% |
| 3 | $8.18 | 6,222 | $51K | 7.5% |
| 4 | $8.18 | 20,093 | $164K | 24.2% |
| 5 | $8.19 | 3,700 | $30K | 4.5% |
| 6 | $8.19 | 8,659 |
| $71K |
| 10.5% |
| 7 | $8.20 | 4,848 | $40K | 5.9% |
| 8 | $8.20 | 1,500 | $12K | 1.8% |
| 9 | $8.20 | 400 | $3K | 0.5% |
| 10 | $8.21 | 100 | $821 | 0.1% |
| 11 | $8.21 | 2,500 | $21K | 3.0% |
| 12 | $8.22 | 2,600 | $21K | 3.2% |
| 13 | $8.23 | 1,570 | $13K | 1.9% |
| 14 | $8.24 | 1,700 | $14K | 2.1% |
| 15 | $8.24 | 2,930 | $24K | 3.6% |
| 16 | $8.25 | 2,098 | $17K | 2.6% |
| 17 | $8.26 | 100 | $826 | 0.1% |
| 18 | $8.26 | 400 | $3K | 0.5% |
| 19 | $8.27 | 1,300 | $11K | 1.6% |
| 20 | $8.28 | 100 | $828 | 0.1% |
| 21 | $8.29 | 5,100 | $42K | 6.2% |
| 22 | $8.29 | 200 | $2K | 0.2% |
| 23 | $8.30 | 5,028 | $42K | 6.2% |
| 24 | $8.31 | 1,374 | $11K | 1.7% |
| 25 | $8.32 | 200 | $2K | 0.2% |
| 26 | $8.33 | 300 | $2K | 0.4% |
| 27 | $8.34 | 500 | $4K | 0.6% |
| 28 | $8.35 | 2,900 | $24K | 3.6% |
| 29 | $8.36 | 100 | $836 | 0.1% |
| Total | $8.22 avg | 82,500 | $678K | 100% |
| Filing → |
| RCPT | SELL | 2014-09-17 | $3.1M | — | Filing → |
| OREX | SELL | 2009-12-23 | $147K | — | Filing → |
| OREX | SELL | 2008-08-25 | $99K | — | Filing → |